Array BioPharma Company Profile
Array BioPharma is a drug discovery company inventing new small molecule drugs through the integration of chemistry, biology and informatics. Our experienced scientists use the Array Discovery Platform, our integrated set of drug discovery technologies, to invent novel small molecule drugs in collaboration with leading pharmaceutical and biotechnology companies and to build our own pipeline of proprietary drug candidates.
Location
3200 Walnut Street
Boulder
80301
United States of America
Contact
Phone: 303-386-1112
Fax: 303-381-6697
Email: IR@arraybiopharma.com.
News Articles
Array BioPharma Achieves $8.5 Million Clinical Milestone in Amgen Diabetes Collaboration
BOULDER, Colo.--(BUSINESS WIRE)--Jul 19, 2012 - Array BioPharma Inc. (NASDAQ: ARRY) announced today that an $8.5 million milestone was achieved in its collaboration with Amgen. Array entered into an a...
Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference
BOULDER, Colo., Dec. 27, 2012 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Annual J.P. Morgan Healthcare Confere...
Array BioPharma to Present at the JMP Securities Healthcare Conference 2012
Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the JMP Securities Healthcare Conference 2012 in New York City. Th...
John A. Orwin Joins Array BioPharma Board Of Directors
BOULDER, Colo., Nov. 7, 2012 /PRNewswire/ --Array BioPharma Inc. (NASDAQ: ARRY) today announced that as part of its continued evolution toward late-stage development and commercialization, John A....
[Array BioPharma] nets $61.8mm through public sale
[Array BioPharma Inc.] netted $61.8mm through a public offering of 18mm common shares at $3.65 each. The company is working on small-molecule therapies for cancer and inflammatory diseases, and also h...
Array BioPharma To Present At The Piper Jaffray Annual Healthcare Conference
BOULDER, Colo., Nov. 15, 2012 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Piper Jaffray Annual Healthcare...
Array BioPharma to Present at the Jefferies 2012 Global Healthcare Conference
Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Jefferies 2012 Global Healthcare Conference in New York City....
Array BioPharma announces public offering of common stock for $65.7 million
Array BioPharma announced the pricing of an underwritten public offering of 18,000,000 primary shares of its common stock at a public offering price of $3.65 per share. The gross proceeds from the sal...
Drugs and Medications
Cardene® sr [PDL BioPharma, Inc.]
CARDENE® SR
Recombinate [Baxter Healthcare Corporation]
RECOMBINATE [Antihemophilic Factor (Recombinant)]
Recombinate [Baxter Healthcare Corporation]
RECOMBINATE [Antihemophilic Factor (Recombinant)]
Recombinate [Baxter Healthcare Corporation]
RECOMBINATE [Antihemophilic Factor (Recombinant)]
Recombinate [Baxter Healthcare Corporation]
RECOMBINATE [Antihemophilic Factor (Recombinant)]
PubMed Articles
Fostering a new dialogue to improve access to finance for European biopharma SMEs.
This article reviews the current economic crisis as it impacts upon European biopharma SMEs and their ability to secure investment and funding. In particular it presents an analysis of a broader, pre-...
A selective and convenient method for the synthesis of 2-phenylaminothiazolines.
A series of 2-phenylaminothiazolines have been prepared from the corresponding N-(2-hydroxyethyl)-N'-phenylthioureas under mild reaction conditions using either thio-CDI (1,1'-thiocarbonyldiimidazole)...
The Discovery of furo2,3-cpyridine-based indanone oximes as potent and selective B-Raf inhibitors.
Virtual and high-throughput screening identified imidazo[1,2-a]pyrazines as inhibitors of B-Raf. We describe the rationale, SAR, and evolution of the initial hits to a series of furo[2,3-c]pyridine in...
Herein we describe a novel series of ATP competitive B-Raf inhibitors based on the pyrazolo[1,5-a]pyrimidine scaffold. These inhibitors exhibit both excellent cellular potency and striking B-Raf selec...
The discovery of potent and selective pyridopyrimidin-7-one based inhibitors of B-Raf(V600E) kinase.
Herein we describe the discovery of a novel series of ATP competitive B-Raf inhibitors via structure based drug design (SBDD). These pyridopyrimidin-7-one based inhibitors exhibit both excellent cellu...
Clinical Trials
Single Ascending Dose Phase 1 Trial in Patients With Type 2 Diabetes
ARRY-403 is an investigational new drug being developed by Array BioPharma Inc. for treating Type 2 diabetes. The purpose of this study is to test the safety (potential side effects) and...
DNA Array Analysis of Patients With Cervical Cancer
Primary Objectives: 1. To obtain preliminary descriptive data on early changes in tumor DNA array expression following chemo-radiation of cervical cancer. These data will permit t...
Scalar Localization Cochlear Electrode Array Using 64 Slice CT
Insertion of electrode array in scala vestibuli, rather than the preferred location within scala tympani, leads to loss of native hearing in those patients with isolated high-frequency hea...
Large Array EMG Discriminability in Discogenic Low Back Pain
Hypothesis: Myoelectric patterns observed from the CERSR array during standardized testing are sensitive in identifying healthy subjects from patients with internal disc derangement and a...
The most reliable prognostic marker of acute myeloid leukemia(AML) is cytogenetics by karyotyping. According to cytogenetic results, the patients with AML are classified as better, interme...
Companies
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small-molecule drugs to treat patients afflicted with c...
Array BioPharma is a drug discovery company inventing new small molecule drugs through the integration of chemistry, biology and informatics. Our experienced scientists use the Array Discovery Platfor...
SAFE-BioPharma Association (www.safe-biopharma.org) is the non-profit association that created and manages the SAFE-BioPharma® digital identity and signature standard for the...
Genesis Biopharma, Inc. is a development-stage biotechnology company engaged primarily in the development of targeted cancer therapies. For more information on the Company, visit http://www.genesis-b...
TenX Biopharma, Inc., is a biopharmaceutical company focused on late stage development and commercialization of novel monoclonal antibody-based cancer therapies. TenX Biopharma acquired global rights...
More Information about "Array BioPharma" on BioPortfolio
We have published hundreds of Array BioPharma news stories on BioPortfolio along with dozens of Array BioPharma Clinical Trials and PubMed Articles about Array BioPharma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Array BioPharma Companies in our database. You can also find out about relevant Array BioPharma Drugs and Medications on this site too.
